Molecular Pathology, Diagnostics, and Therapeutics

Special Issues

Following special issues within this section are currently open for submissions:

• Understanding Traumatic Brain Injury: Mechanisms and Therapeutic Targets 3.0 (Deadline: 30 May 2022)
• Targeted Cancer Therapy and Mechanisms of Resistance 2.0 (Deadline: 30 May 2022)
• Neuroprotection: Rescue from Neuronal Death in the Brain 2.0 (Deadline: 30 May 2022)
• Intercellular and Intracellular Communication in Human Health and Disease 2.0 (Deadline: 30 May 2022)
• Pathogenesis and Treatment of Cutaneous Lymphoma (Deadline: 30 May 2022)
• Oxidative Stress and Skeletal Muscle Function (Deadline: 30 May 2022)
• Molecular Approaches for Understanding Dengue Disease (Deadline: 30 May 2022)
• MicroRNA Signaling in Human Diseases 2.0 (Deadline: 31 May 2022)
• Atherosclerosis: From Molecular Biology to Therapeutic Perspective 2.0 (Deadline: 31 May 2022)
• Retinal Degeneration: From Pathophysiology to Therapeutic Approaches 3.0 (Deadline: 31 May 2022)
• Molecular Mechanisms of Kidney Injury (Deadline: 31 May 2022)
• The Emerging Role of RNA in Diseases and Cancers (Deadline: 31 May 2022)
• MicroRNA in Cardiac Health and Disease (Deadline: 31 May 2022)
• The Physiology of Striated Muscle Tissues (Deadline: 31 May 2022)
• Cellular Senescence in Physiological and Pathological Processes (Deadline: 31 May 2022)
• Sirtuins and Epigenetics in Aging and Diseases 2.0 (Deadline: 31 May 2022)
• Emerging Treatment for Cardiovascular Diseases (Deadline: 31 May 2022)
• Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery 2.0 (Deadline: 31 May 2022)
• Molecular Mechanisms of Angiogenesis in Health and Diseases (Deadline: 31 May 2022)
• Therapeutic Strategies and Targets for Reactive Oxygen Species Related Diseases (Deadline: 31 May 2022)
• Molecular Mechanisms of Drug-Induced, Immune-Mediated Liver Injury (Deadline: 31 May 2022)
• Human and Animal Monocytes and Macrophages in Homeostasis and Disease 3.0 (Deadline: 31 May 2022)
• Metabolic Disturbances in Hematologic Malignancies (Deadline: 31 May 2022)
• Molecular Advances in Skin Diseases (Deadline: 31 May 2022)
• New Applications in the Diagnosis and Therapy of Diseases (Deadline: 31 May 2022)
• The Role of Oxidative Stress and Epithelium-Derived Cytokines in Atopic Dermatitis (Deadline: 31 May 2022)
• The Role of Extracellular Matrix in Human Health and Disease (Deadline: 31 May 2022)
• New Insights into Psoriasis (Deadline: 31 May 2022)
• RNA Modifications in Disease and Development (Deadline: 31 May 2022)
• Sarcomere Function in Health and Disease (Deadline: 31 May 2022)
• Thyroid Hormones and NAFLD: New Insights 2.0 (Deadline: 31 May 2022)
• Angiogenesis and Lymphangiogenesis in Cancer (Deadline: 31 May 2022)
• MicroRNAs and Stem Cells 3.0 (Deadline: 31 May 2022)
• Molecular Advances in Alzheimer's Disease (Deadline: 31 May 2022)
• Cardiac Repair and Regeneration: New Molecular Mechanisms and Therapeutics 2.0 (Deadline: 31 May 2022)
• Purinergic Signaling in Neuroinflammation 2.0 (Deadline: 31 May 2022)
• Mechanisms of Cancer Development in Diabetes (Deadline: 31 May 2022)
• Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 2.0 (Deadline: 31 May 2022)
• Embracing the Diversity of Perinatal Brain Injury: Molecular Mechanisms and Novel Therapeutics (Deadline: 15 June 2022)
• Gene Expression and Molecular Targets of Oral Cancer and Periodontal Diseases (Deadline: 15 June 2022)
• Scientific Discoveries Supporting Theories in Science: From Thinking to Practice (Deadline: 15 June 2022)
• Cellular and Molecular Mechanisms in Oxidative Stress-Related Diseases (Deadline: 20 June 2022)
• Molecular Research on Emerging Mosquito-Transmitted RNA Viruses 3.0 (Deadline: 29 June 2022)
• Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases (Deadline: 29 June 2022)
• Molecular and Cellular Mechanisms of Brain Disease: Hippocampus as a Nodal Point (Deadline: 30 June 2022)
• Transcription in Cancer Initiation and Progression (Deadline: 30 June 2022)
• Filaggrin (Deadline: 30 June 2022)
• Current Mechanistic Understandings of Lymphedema and Lipedema (Deadline: 30 June 2022)
• New Pharmacological Approaches for Rare Diseases (Deadline: 30 June 2022)
• Telomeres and Human Disease (Deadline: 30 June 2022)
• Host Microbiota and Cancer: From Pathogenic Mechanisms to Therapy (Deadline: 30 June 2022)
• Regulation of Trace Metals in Neurodegenerative and Neurodevelopmental Disorders (Deadline: 30 June 2022)
• Dual Targeting as a Strategy to Counteract Chronic Diseases (Deadline: 30 June 2022)
• Advanced Research on Neurological Disorders: From Novel Molecular Mechanism to Innovative Therapeutic Paradigm (Deadline: 30 June 2022)
• Molecular Advances in Breast Cancer (Deadline: 30 June 2022)
• Pro-inflammatory Nutrients: Focus on Gliadin and Celiac Disease 2.0 (Deadline: 30 June 2022)
• Molecular Advances in Lung Diseases (Deadline: 30 June 2022)
• Neuropilins and VEGFR-Interacting Proteins in Health and Disease (Deadline: 30 June 2022)
• Bladder Cancer 2.0 (Deadline: 30 June 2022)
• Hematopoietic Stem Cells and Disease Treatment (Deadline: 30 June 2022)
• Cellular and Molecular Research of Kidney Diseases (Deadline: 30 June 2022)
• Retinal Pigment Epithelium: Molecular Mechanisms of Homeostasis and Function (Deadline: 30 June 2022)
• Atherosclerotic and Cardiometabolic Disease: From Molecular Basis to Therapeutic Advances (Deadline: 30 June 2022)
• Advances in Molecular Research on Prostate Cancer (Deadline: 30 June 2022)
• New Strategies Protecting from Ischemia/Reperfusion (Deadline: 30 June 2022)
• mTOR Signaling Network in Cell Biology and Human Disease (Deadline: 30 June 2022)
• Molecular Research in Uterine Biology and Pathophysiology (Deadline: 30 June 2022)
• Fatty Acids and Inflammation: From Biochemistry to Human Evidence (Deadline: 30 June 2022)
• Impact of Dyslipidemia and Metabolic Syndrome on Cardiac Dysfunction (Deadline: 30 June 2022)
• Molecular Advances in SARS-CoV-2 Transmission, Infection and Pathology (Deadline: 30 June 2022)
• Role of G-Protein Coupled Receptors in Cardiovascular Diseases (Deadline: 30 June 2022)
• Molecular Research in Antidepressant Response (Deadline: 30 June 2022)
• Molecular Mechanisms and Pathophysiology of Head and Neck Diseases (Deadline: 30 June 2022)
• Immunotherapies for Cancer (Deadline: 30 June 2022)
• In Vitro Models of Tissue and Organ Regeneration (Deadline: 30 June 2022)
• Biology and Pathology of the Human Hair Follicle (Deadline: 30 June 2022)
• Osteoporosis: From Molecular Mechanisms to Therapies 3.0 (Deadline: 30 June 2022)
• Mechanisms of Therapeutic Peptides (Deadline: 30 June 2022)
• Integrin Signaling and Human Pathologies 2021 (Deadline: 30 June 2022)
• Molecular Advances in Thrombotic Microangiopathy and Thrombotic Complications (Deadline: 30 June 2022)
• The Role of Reactive Oxygen Species (ROS) in the Immune System and Health (Deadline: 30 June 2022)
• Prostate Cancer: Stroma Implication in Progression, Diagnosis and Prognosis (Deadline: 30 June 2022)
• Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases (Deadline: 30 June 2022)
• Nutrient Metabolites and Their Receptors in Human Diseases (Deadline: 30 June 2022)
• RNA-Binding Proteins and Their Emerging Roles in Cancer 2.0 (Deadline: 30 June 2022)
• Targeted Protein Degradation (Deadline: 30 June 2022)
• Molecular Mechanisms of Multiple Sclerosis Pathology (Deadline: 30 June 2022)
• Lipid and Atherosclerosis (Deadline: 30 June 2022)
• Focus on Wound Healing (Deadline: 30 June 2022)
• Molecular Studies of Glioblastoma (Deadline: 30 June 2022)
• Renin-Angiotensin-Aldosterone System in Pathologies (Deadline: 30 June 2022)
• Glaucoma: From Pathophysiology to Novel Therapies (Deadline: 30 June 2022)
• Smart Biomaterials in Tissue Regeneration (Deadline: 30 June 2022)
• Molecular Imaging in Precision Medicine: A Challenging Alliance (Deadline: 30 June 2022)
• Inflammatory Bowel Diseases: Pathogenesis and Future Developments (Deadline: 30 June 2022)
• Mechanisms of Lung Vascular Remodeling in Acute and Chronic Lung Diseases (Deadline: 30 June 2022)
• Coronavirus Disease (COVID-19): Pathophysiology 2.0 (Deadline: 30 June 2022)
• Extracellular Vesicles and Metastatic Niche 3.0 (Deadline: 1 July 2022)
• Extracellular Matrix in Development and Disease 3.0 (Deadline: 15 July 2022)
• Congenital and Acquired Platelet Disease 2.0 (Deadline: 15 July 2022)
• The Role of MSCs on Inflammatory and Fibrotic Diseases (Deadline: 15 July 2022)
• Molecular Mechanisms and Biomarkers in Drug-Associated Organ Injury (Deadline: 15 July 2022)
• Changes in Retinal Disease in Association with Choroid (Deadline: 15 July 2022)
• Unraveling the Molecular Pathways of Alzheimer's Disease (Deadline: 20 July 2022)
• Advances in Molecular and Translational Medicine (Deadline: 29 July 2022)
• Molecular Advances in Colorectal Cancer (Deadline: 30 July 2022)
• Molecular Advances in MAFLD (Deadline: 30 July 2022)
• The Role of Fibrinolytic System in Health and Disease 2.0 (Deadline: 31 July 2022)
• New Perspectives in Molecular Diagnosis of Neuromuscular Disorders (Deadline: 31 July 2022)
• Frontiers in Anti-aging Treatment Development (Deadline: 31 July 2022)
• Compounds with Anxiolytic or Antidepressant Properties (Deadline: 31 July 2022)
• Recent Advances in Salivary Gland and Their Function 2.0 (Deadline: 31 July 2022)
• New Paradigms in Aldosterone and Mineralocorticoid Receptor Pathophysiology (Deadline: 31 July 2022)
• Biogenesis and Functional Roles of Lysosomes: Their Implications for the Pathogenesis and Therapy of Human Diseases 2.0 (Deadline: 31 July 2022)
• Frontier Research on Retina (Deadline: 31 July 2022)
• Molecular Research in Renal Tumors (Deadline: 31 July 2022)
• Advanced Research on Reproductive System Disease 2022 (Deadline: 31 July 2022)
• The Molecular Basis of Complications and Pitfalls in Radiotherapy and Potent Methods for Compromise (Deadline: 31 July 2022)
• Molecular Biology of Hereditary Tumors (Deadline: 31 July 2022)
• Role and Application of Stem Cells in Regenerative Medicine 3.0 (Deadline: 31 July 2022)
• Role of Non-coding RNAs and Untranslated RNA Regions in Disease (Deadline: 31 July 2022)
• Osteoblast Differentiation and Activity in Skeletal Diseases 2.0 (Deadline: 31 July 2022)
• Mitochondrial Dysfunction: A Common Trigger in Neurodegenerative and Metabolic Non-communicable Diseases (Deadline: 31 July 2022)
• Molecular Research in Radiobiology 2.0 (Deadline: 31 July 2022)
• Osteosarcoma: Molecular Alterations, Heredity, and Metabolism (Deadline: 31 July 2022)
• Zebrafish as a Model in Human Disease (Deadline: 31 July 2022)
• Neuroinfectiology: Molecular and Cellular Mechanisms of Neurotropic Virus Infection 3.0 (Deadline: 31 July 2022)
• Cell Programming for Cardiovascular Disease Modeling and Therapy 2.0 (Deadline: 31 July 2022)
• Advanced Models of Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Organ-on-a-Chips (Deadline: 31 July 2022)
• DNA Replication Stress and Chromosomal Instability 2.0 (Deadline: 31 July 2022)
• Mechanisms of Adiponectin Action 3.0 (Deadline: 31 July 2022)
• Apolipoproteins in Health and Disease (Deadline: 31 July 2022)
• Sepsis: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 July 2022)
• Advanced Research in Cardiopulmonary Injury (Deadline: 31 July 2022)
• New Insights in Cardiac Ischemic Diseases (Deadline: 31 July 2022)
• Role of ncRNAs Classes as Biomarkers for Diagnostic and Prognosis in Cancer 2021 (Deadline: 31 July 2022)
• New Insight and Perspectives in Non-melanoma Skin Cancer: From Histopathological Diagnostics to Molecular Biology (Deadline: 31 July 2022)
• Novel Insights in Retinal Diseases Pathophysiology and Therapies (Deadline: 31 July 2022)
• Physiological and Pathological Aspects of Unfolded Protein Response 2.0 (Deadline: 31 July 2022)
• Infections, Inflammation and Neurodegeneration in Alzheimer’s Disease 2.0 (Deadline: 31 July 2022)
• Molecular Regulations in Neural Central Development and Morphogenesis (Deadline: 31 July 2022)
• Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 3.0 (Deadline: 31 July 2022)
• New Insight into Nutrient Response and Adaptation: From Molecular Mechanism to Metabolic Reprogramming (Deadline: 31 July 2022)
• Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0 (Deadline: 31 July 2022)
• Molecular Insights and Multi-Omics in Sleep Disorders (Deadline: 31 July 2022)
• Therapeutic Potential of Targeting Connexins in Managing Disease Onset and Progression 2.0 (Deadline: 31 July 2022)
• Exosomes in Cancer Diagnosis and Therapy 2.0 (Deadline: 31 July 2022)
• Collagen VI-Related Myopathies—COL6-RMs (Deadline: 31 July 2022)
• The Role of Autophagy Processes in Human Diseases (Deadline: 31 July 2022)
• Regulatory Mechanisms of Ion Channels and Their Potential as Therapeutic Targets (Deadline: 31 July 2022)
• Molecular Pathophysiology of Chronic Lung Disease (Deadline: 31 July 2022)
• Pathological Mechanisms Involved in Restenosis Progression (Deadline: 31 July 2022)
• Advances in the Pathogenesis and Treatment of Hypertension (Deadline: 31 July 2022)
• Musculoskeletal Metabolism and Inflammation (Deadline: 31 July 2022)
• Mucopolysaccharidoses: Diagnosis, Treatment, and Management 3.0 (Deadline: 31 July 2022)
• Lipid and Metabolic Syndrome (Deadline: 31 July 2022)
• Emerging Viruses: Molecular Mechanisms of Native and Artificial Immune Response (Deadline: 31 July 2022)
• New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases (Deadline: 31 July 2022)
• Molecular Research of Vascular Aspects in Pregnancy (Deadline: 31 July 2022)
• New Insights into Adipose Tissue Metabolic Function and Dysfunction (Deadline: 31 July 2022)
• Molecular Targeted Therapeutic Strategies for Glioblastoma (Deadline: 31 July 2022)
• Zebrafish as an Experimental Model for Human Disease (Deadline: 31 July 2022)
• Protease-Protease Inhibitors in the Retinal Disease (Deadline: 31 July 2022)
• Molecular Research in Oral Diseases (Deadline: 31 July 2022)
• Diabetic Kidney Diseases (Deadline: 31 July 2022)
• Recent Approaches for Wound Treatment (Deadline: 31 July 2022)
• Ion Channels in Sperm Physiology 2.0 (Deadline: 31 July 2022)
• Molecular Research in Atherosclerosis (Deadline: 31 July 2022)
• Whole Joint Philosophy for the Treatment of Early Osteoarthritis: Cellular and Molecular Perspectives (Deadline: 31 July 2022)
• The Role of MicroRNAs, tRNA Fragments, and Circular RNAs in Leukemia (Deadline: 31 July 2022)
• The Role of the Circadian Clock in Cancer and Inflammatory Diseases (Deadline: 31 July 2022)
• Similarities and Differences between Chimeric Antigen Receptor and T Cell Receptor Signaling (Deadline: 1 August 2022)
• Molecular Mechanisms of an Aberrant Specific Immune Response: Role in Pathogenesis of Infectious, Autoimmune Diseases and Cancer (Deadline: 20 August 2022)
• Pathobiology of Acute Kidney Injury 2.0 (Deadline: 20 August 2022)
• Molecular Research of Hematological Changes in Cardiovascular Diseases (Deadline: 28 August 2022)
• Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue (Deadline: 30 August 2022)
• Recent Advances in Glycoproteomics: Theory, Methods and Applications (Deadline: 30 August 2022)
• Thromboinflammation: An Evolving Multifaceted Concept (Deadline: 30 August 2022)
• Molecular Research on Cardiomyopathy 2.0 (Deadline: 30 August 2022)
• Neuroblastoma Molecular Biology and Therapeutics 2.0 (Deadline: 30 August 2022)
• The Physiology and Pathophysiology of the Erythrocyte (Deadline: 31 August 2022)
• Antimicrobial Peptides and Antimicrobial Chemokines 2.0 (Deadline: 31 August 2022)
• DNA Damage, Oxidative Stress and Human Disease (Deadline: 31 August 2022)
• Multiple Myeloma Bone Disease: Symptoms, Diagnosis and Treatment 2.0 (Deadline: 31 August 2022)
• Molecular Mechanisms in Simultaneous Development of Lower Urinary Tract Symptoms and Erectile Dysfunction (Deadline: 31 August 2022)
• Gene and Cell Therapy for Ophthalmology Disease (Deadline: 31 August 2022)
• Tumor Metabolism and Immune Evasion (Deadline: 31 August 2022)
• Cancer Immunotherapies and NK/CIK/CAR-T (Deadline: 31 August 2022)
• Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 August 2022)
• Cystic Fibrosis and CFTR Interactions (Deadline: 31 August 2022)
• Molecular Biology of Age-Related Macular Degeneration (AMD) 3.0 (Deadline: 31 August 2022)
• Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation 2.0 (Deadline: 31 August 2022)
• Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials (Deadline: 31 August 2022)
• Molecular Research and Treatment of Skin Diseases 2.0 (Deadline: 31 August 2022)
• Chronic Myeloid Leukemia: From Molecular Mechanisms to Targeted Therapies (Deadline: 31 August 2022)
• Transglutaminase Diseases, from the Experimental Laboratory to Human Pathology Applications 2.0 (Deadline: 31 August 2022)
• Metabolic Regulators of Psychological Stress and Brain Trauma (Deadline: 31 August 2022)
• Cytokines: From Cancer to Autoimmunity (Deadline: 31 August 2022)
• Recent Advances in Acute Myeloid Leukemia in Children (Deadline: 31 August 2022)
• Targeted Biomarkers for Combinatorial Therapies in Neuroinflammation and Brain Tumors (Deadline: 31 August 2022)
• Adipokines, Myokines and Physical Exercise in Health and Disease (Deadline: 31 August 2022)
• Research Progress of Platelet Metabolism in Regulating Platelet Function and Thrombosis (Deadline: 31 August 2022)
• State-of-the-Art Molecular Mechanisms of Hematopathology in Korea (Deadline: 31 August 2022)
• Recent Advances in Intermediate Filaments 2.0 (Deadline: 31 August 2022)
• Immunological Approaches in Tumor Therapy (Deadline: 31 August 2022)
• The Crosstalk between Adipose Tissue and Cancer (Deadline: 31 August 2022)
• Melanosome Transport/Transfer and Melanin Pigmentation in the Skin 2.0 (Deadline: 31 August 2022)
• Molecular Links between Periodontitis and Systemic Diseases 2.0 (Deadline: 31 August 2022)
• Study of Endoplasmic Reticulum Stress and Unfolded Protein Response (Deadline: 31 August 2022)
• New Frontiers in Musculoskeletal Tissue Repair and Tissue Regeneration (Deadline: 31 August 2022)
• Nuclear Receptors in Health and Diseases (Deadline: 31 August 2022)
• From Pathogenesis to Treatment—New Perspectives in Rheumatology (Deadline: 31 August 2022)
• Mechanisms of Inflammation in Degenerative Cardiovascular Conditions 3.0 (Deadline: 31 August 2022)
• Non-coding RNAs and Novel Therapeutic Targets in Human Cancers and Ageing-Related Diseases (Deadline: 31 August 2022)
• Frontiers on Induced Pluripotent Stem Cells (iPSCs) (Deadline: 31 August 2022)
• MicroRNA-Based Cancer Therapy 2022 (Deadline: 31 August 2022)
• Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping (Deadline: 31 August 2022)
• Novel Insights into Cancer Drug Resistance: From Molecular Basis to Emerging Therapeutic Strategies (Deadline: 31 August 2022)
• Abnormal Regulation of Cellular Actions of Cardiovascular Factors (Deadline: 31 August 2022)
• Redox Balance and Materials Used in the Treatment of Craniofacial Diseases (Deadline: 31 August 2022)
• The Tumor Microenvironment and Immune System in Biliopancreatic Cancers (Deadline: 31 August 2022)
• Innovation through Tradition: The Current Challenges in Cancer Treatment 2.0 (Deadline: 31 August 2022)
• Current Trends of Natural Bioactive Molecules in Regulation of Cell Signaling Pathways in Different Diseases (Deadline: 31 August 2022)
• Ion Channels and Transporters: The New Targets for Cancer (Deadline: 31 August 2022)
• Molecular Research on Rett Syndrome and Related Disorders: From the Past towards the Future 2.0 (Deadline: 31 August 2022)
• Molecular Research on Cancer Stem Cell (Deadline: 31 August 2022)
• Molecular Pathogenesis and Therapeutics in Urothelial Carcinoma (Deadline: 31 August 2022)
• Pathophysiology and Treatment of Inflammatory Bowel Disease (Deadline: 31 August 2022)
• Therapeutic Aspects of Gasotransmitters in Cardiovascular and Renal Disease 2.0 (Deadline: 31 August 2022)
• New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0 (Deadline: 31 August 2022)
• Molecular Mechanisms and Extracerebral Factors Affecting Brain Injury (Deadline: 31 August 2022)
• Common Molecular Mechanisms in Embryonic Development (Deadline: 31 August 2022)
• Therapeutic Potentials of Natural Products on Cerebrovascular Diseases and Neurodegeneration (Deadline: 31 August 2022)
• Photodynamic Therapy and Photodetection (Deadline: 1 September 2022)
• Sleep Apnea and Intermittent Hypoxia 3.0 (Deadline: 15 September 2022)
• Recent Advances in the Inverse Relationship of Cancer and Alzheimer’s Disease (Deadline: 17 September 2022)
• Molecular Pathogenesis and Treatment in Neurodegeneration: Current Evidence and Future Directions (Deadline: 20 September 2022)
• Transgenic Mice in Human Diseases: Insights from Molecular Research 3.0 (Deadline: 20 September 2022)
• Fate of Pancreatic Islets in Type 2 Diabetes (Deadline: 25 September 2022)
• Molecular Markers and Targets in Acute Myeloid Leukemia (Deadline: 30 September 2022)
• Protein Kinase in Disease (Deadline: 30 September 2022)
• Liver Damage and Repair 2.0 (Deadline: 30 September 2022)
• Towards Precision Prognostication and Personalized Therapeutics through Proteomics (Deadline: 30 September 2022)
• Molecular Mechanisms of Ischemia-Induced Renal Fibrosis (Deadline: 30 September 2022)
• Targeted Therapies and Molecular Methods in Cancer (Deadline: 30 September 2022)
• Non-coding RNAs in Tumor Development and Angiogenesis (Deadline: 30 September 2022)
• Role of Drosophila in Human Disease Research 3.0 (Deadline: 30 September 2022)
• The Emerging Role of Non-ionizing Radiation in Biomedical Applications (Deadline: 30 September 2022)
• Zebrafish as an Experimental Model for Metabolic Disease: From Morphology to Therapy the Key Role of Translational Research in Biomedicine (Deadline: 30 September 2022)
• Advanced Research in Regenerative Ophthalmology (Deadline: 30 September 2022)
• Muscle Atrophy: From Bench to Bedside (Deadline: 30 September 2022)
• Advances in Molecular Research and Novel Diagnostic Technics of Hematological Malignancies (Deadline: 30 September 2022)
• The Microbiota–Gut–Brain Axis in Behaviour and Brain Disorders (Deadline: 30 September 2022)
• Genetic and Molecular Mechanisms of Liver Disease (Deadline: 30 September 2022)
• Role of Telomeres and Telomerase in Cancer and Aging 2022 (Deadline: 30 September 2022)
• Molecular Diagnosis and Treatment of Skin Cancers (Deadline: 30 September 2022)
• BMP Signaling and TGF-β Family in Cancer Development (Deadline: 30 September 2022)
• Molecular Mechanisms of Cardiovascular Disease 2022 (Deadline: 30 September 2022)
• Advances in Ischemic Retinopathies (Deadline: 30 September 2022)
• The Emerging Role of Kinase Inhibitors in Cancer (Deadline: 30 September 2022)
• 2nd Edition: Molecular Mechanisms Regulating Osteoclastogenesis (Deadline: 30 September 2022)
• Molecular Advances in Aldosterone and Aldosterone Related Disorders (Deadline: 30 September 2022)
• Homeostasis: Metals and Cellular Redox and Immunity Status (Deadline: 30 September 2022)
• New Advance in Corneal Dystrophies (Deadline: 30 September 2022)
• Molecular and Cellular Factors Regulating Signal Transduction, Diseases, and Stem Cells (Deadline: 30 September 2022)
• Tumor Microenvironment and Its Actors: Are Ion Channels Relevant? (Deadline: 30 September 2022)
• Emerging Concepts and Novel Therapeutics to Overcome Treatment Resistance in Prostate Cancer (Deadline: 30 September 2022)
• Review of Cardiac Fibrosis: Recent Advances and Future Directions 2022 (Deadline: 30 September 2022)
• Genome Editing Therapy Using Viral Vectors of Adenovirus and Lentivirus (Deadline: 30 September 2022)
• HPV Elimination: A Highway to the Elimination of HPV-Associated Cancers (Deadline: 30 September 2022)
• Molecular Pathology, Diagnostics, and Therapeutics of Nephropathy 2.0 (Deadline: 30 September 2022)
• Molecular Mechanisms of Periodontal Disease 3.0 (Deadline: 30 September 2022)
• Advance in Reproductive Biology and Related Diseases (Deadline: 30 September 2022)
• The Role of Ion-Transporting Proteins in Human Disease (Deadline: 30 September 2022)
• Novel Molecular Approaches to Skeletal Muscle Disease and Disuse 2.0 (Deadline: 30 September 2022)
• Gene Transfer in Microorganisms and Human Diseases (Deadline: 30 September 2022)
• Mesothelial Cell: Its Repair, Plasticity, and Relationship with Tumor Dissemination (Deadline: 30 September 2022)
• Ovarian Disorders: From Molecular Basis to Therapeutic Advances (Deadline: 30 September 2022)
• The Role of G Protein-Coupled Receptor in Human Disease (Deadline: 30 September 2022)
• Targeting Mitochondria in Aging and Disease 2.0 (Deadline: 30 September 2022)
• Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment (Deadline: 30 September 2022)
• Emerging Molecular Mechanisms for the Diagnosis and Treatment of Fragile X Syndrome (Deadline: 30 September 2022)
• Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 3.0 (Deadline: 30 September 2022)
• Mechanisms of Cardiovascular Disease: Molecular Perspective 2.0 (Deadline: 30 September 2022)
• Protein Folding Diseases—Molecular Mechanisms and Therapeutic Approaches (Deadline: 30 September 2022)
• Non-coding RNAs in Cancer, Aging and Regeneration (Deadline: 30 September 2022)
• Extracellular Vesicles in Microbes, Pathogens and Infectious Diseases (Deadline: 30 September 2022)
• Stroke: Merging Neuroprotection and Neuroregeneration towards Therapeutics 2.0 (Deadline: 30 September 2022)
• Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies 2.0 (Deadline: 30 September 2022)
• Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases (Deadline: 30 September 2022)
• Gut and the Liver in Health and Disease (Deadline: 30 September 2022)
• Neural Stem Cells: Focusing on Disease Modeling and Translational Application (Deadline: 30 September 2022)
• Molecular Mechanism and Application of Somatic Cell Cloning in Mammals (Deadline: 30 September 2022)
• The Kinase Inhibitors in Human Diseases (Deadline: 30 September 2022)
• Endocannabinoids, Cannabinoids and Psychiatry: Biological Mechanisms 2.0 (Deadline: 30 September 2022)
• Pluripotent Stem Cells and Organoids on Disease Modeling and Therapeutic Potentials (Deadline: 30 September 2022)
• Matricellular Proteins in Human Diseases (Deadline: 30 September 2022)
• Arteriogenesis, Angiogenesis and Vascular Remodeling (Deadline: 1 October 2022)
• Cell Death in Acute Organ Injury and Fibrosis (Deadline: 10 October 2022)
• GPR37 and Related Receptors: Disease Regulation (Deadline: 15 October 2022)
• Aging and Heart Disease (Deadline: 15 October 2022)
• Pathophysiologic Mechanisms of Eye Diseases and Novel Therapeutic Approaches (Deadline: 15 October 2022)
• Bone and Soft Tissue Sarcomas - Basic Research and Multimodal Treatment Concepts (Deadline: 20 October 2022)
• The Role and Characterization of Neutrophils in Human Diseases (Deadline: 20 October 2022)
• Skeletal Muscle and Metabolic Disorders (Deadline: 25 October 2022)
• Molecular Features of Skin Cancer (Deadline: 27 October 2022)
• Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy 2.0 (Deadline: 30 October 2022)
• Vasculitis (Deadline: 30 October 2022)
• Biomarkers in Rare Diseases 3.0 (Deadline: 30 October 2022)
• Regenerative Medicine Protocols: From Molecular Research to Application (Deadline: 30 October 2022)
• Autoimmunity and COVID-19 (Deadline: 30 October 2022)
• Molecular Imaging in Diabetes, Obesity, and Infections 3.0 (Deadline: 30 October 2022)
• Contribution of Dysfunctional Microvasculature to Cardiovascular Diseases (Deadline: 30 October 2022)
• Application of Advanced Molecular Methods to Study Infections (Deadline: 30 October 2022)
• New Insights into Glioblastoma: Cellular and Molecular (Deadline: 31 October 2022)
• Recent Research in Primary Osteoporosis: From a Bone Marrow Adiposity Perspective (Deadline: 31 October 2022)
• Molecular Pathological Mechanisms of Skin Cancer (Deadline: 31 October 2022)
• Strategies to Counteract Oxidative Stress and Inflammation in Chronic-Degenerative Diseases 2.0 (Deadline: 31 October 2022)
• CAR-T Cell Therapy 2.0 (Deadline: 31 October 2022)
• Wound Repair and Regeneration 2022 (Deadline: 31 October 2022)
• New Therapeutic Tools in Diabetic Retinopathy (Deadline: 31 October 2022)
• Hearing Loss: Molecular Mechanisms, Treatment and Prevention (Deadline: 31 October 2022)
• Molecular and Cellular Mechanisms of Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases (Deadline: 31 October 2022)
• Leptin and Relatives: Molecules at the Crossroad of Inflammation and Immunometabolism 2.0 (Deadline: 31 October 2022)
• Molecular Research of Cerebrovascular and Neurological Disorders: Role of Oxidative Stress and Pro-inflammatory Stimuli, Volume II (Deadline: 31 October 2022)
• Neurodegeneration 2022: From Genetics to Molecules (Deadline: 31 October 2022)
• Blood-Brain Barrier in CNS Injury and Repair 2022 (Deadline: 31 October 2022)
• Blood Immune and Circulating Tumor Cells (Deadline: 31 October 2022)
• Advances in the Comprehension of the Molecular Basis of Cancer and New Therapeutic Strategies 2021 (Deadline: 31 October 2022)
• Pathological and Molecular Markers for Diagnosis, Prognostic and Therapeutics of Prostate Cancers (Deadline: 31 October 2022)
• Advances of Chromatin in Human Diseases (Deadline: 31 October 2022)
• Molecular Mechanisms Associated with Drug Addiction Vulnerability (Deadline: 31 October 2022)
• Retinal Neurodegenerative Diseases: Molecular Targets Driving Neuroinflammation and Neuroprotection 2022 (Deadline: 31 October 2022)
• Barrier Function of Skin and Oral Mucosa 2.0 (Deadline: 31 October 2022)
• Molecular Mechanisms Underlying Chronic and Degenerative Diseases (Deadline: 31 October 2022)
• Molecular Research of Autophagy and Apoptosis 2022 (Deadline: 31 October 2022)
• Pediatric Lung Diseases: Novel Molecular Insights and Therapeutic Advances (Deadline: 31 October 2022)
• Advances in Metabolism, Immunology, Genetics in Thyroid Cancer and Thyroid Disease: From Bench to Therapy (Deadline: 31 October 2022)
• Molecular Research on Platelet Activity in Health and Disease 2022 (Deadline: 31 October 2022)
• Cross-Talk between Obesity and Eye Diseases: Pathogenesis and Preventive/Therapeutic Strategies (Deadline: 31 October 2022)
• Role of Interleukins in Cutaneous Diseases and Novel Therapeutic Approaches (Deadline: 31 October 2022)
• Melanoma Tissue Structure, Cell Composition, Interactions and Metabolism: From Cancer Pathology to Therapeutic Strategies (Deadline: 31 October 2022)
• Diabetes and Dementia (Deadline: 31 October 2022)
• Sustainable Approaches in Skin Conditions (Deadline: 31 October 2022)
• Highlights in Pathophysiology of the Musculoskeletal System (Deadline: 31 October 2022)
• Looking into the Skin in Health and Disease: From Microscopy Imaging Techniques to Molecular Analysis (Deadline: 31 October 2022)
• The Role of microRNA in Human Diseases (Deadline: 31 October 2022)
• Updates & New Concepts in Collagen (Deadline: 31 October 2022)
• Pathogenesis of Pregnancy-Related Complication (Deadline: 31 October 2022)
• Tumor Microenvironment from a Precision Medicine Perspective 2.0 (Deadline: 31 October 2022)
• Male Fertility: New Horizons for Investigating Reproductive System Diseases (Deadline: 31 October 2022)
• Molecular Research on Pancreatic Cancer: From Pathology to Therapy (Deadline: 31 October 2022)
• Advances in the Molecular of Lung Disease (Deadline: 31 October 2022)
• Molecular Mechanisms of Renal Diseases (Deadline: 31 October 2022)
• Revolving from Hypertension to Cardiovascular Disease (Deadline: 31 October 2022)
• Targeted Nanoparticles and Specific Cell Targeting Strategies for Chronic Liver Disease (Deadline: 31 October 2022)
• New Molecular and Mechanistic Basis for the Inflammasome Manipulation in Cancer and Disease (Deadline: 31 October 2022)
• Targeted Treatments in Cancer (Deadline: 31 October 2022)
• Aging and Senescence 3.0 (Deadline: 31 October 2022)
• Molecular Mechanisms of Endocrine-Disrupting Chemicals (EDC) Action in the Pathogenesis of Human Diseases (Deadline: 31 October 2022)
• The Gas6/TAM System at the Crossroads of Inflammation and Fibrosis (Deadline: 31 October 2022)
• Mitochondrial Respiration in Physiology and Pathology (Deadline: 31 October 2022)
• Advances in Molecular Biology and Targeted Therapy of Leukemias 4.0 (Deadline: 31 October 2022)
• Molecular Mechanisms of Kidney Disease: From Neonates to Adolescents (Deadline: 31 October 2022)
• Retinal Degenerative Diseases (Deadline: 31 October 2022)
• Advanced Molecular Insights into Renal Disorders (Deadline: 31 October 2022)
• Rare Disease Modelling and Its Vital Role in Human Health (Deadline: 31 October 2022)
• Cardiac Diseases: Molecular Pathology, Diagnostics, and Therapeutics (Deadline: 31 October 2022)
• Advances in Molecular Mechanism of Head and Neck Cancer (Deadline: 31 October 2022)
• miRNAs Mediated Post-transcriptional Regulation in Nervous System (Deadline: 1 November 2022)
• Molecular Research on Acute Lymphoblastic Leukemia 2.0 (Deadline: 10 November 2022)
• Hidradenitis Suppurativa and Related Disorders (Deadline: 15 November 2022)
• Purinergic Signalling in Physiology and Pathophysiology (Deadline: 15 November 2022)
• Photodynamic Therapy: Outlook and Future Direction (Deadline: 15 November 2022)
• New Advances in Hepatitis Virus Infection (Deadline: 15 November 2022)
• Genomic Variation of SARS-CoV-2 (Deadline: 15 November 2022)
• The Role of Ceramide Kinase in Cancer, Neurodegeneration, and Inflammation (Deadline: 15 November 2022)
• Advances in Molecular Studies of Solid Tumors (Deadline: 15 November 2022)
• Multifaceted and Diversified Roles of MicroRNAs in Health, Diseases and Death (Deadline: 16 November 2022)
• Psychedelic Drugs and Beyond (Deadline: 20 November 2022)
• Spinal Cord Injury: From Mechanisms to Therapeutic Approaches (Deadline: 28 November 2022)
• Advances in the Pharmacological Treatment of Dementia (Deadline: 30 November 2022)
• Molecular Decision Making in the Treatment of Colorectal Liver Metastases (Deadline: 30 November 2022)
• Oxidative Stress and Brain Injury 3.0 (Deadline: 30 November 2022)
• Recent Advances in Skin Disease and Comorbidities (Deadline: 30 November 2022)
• Molecular Advances in Infectious Disease (Deadline: 30 November 2022)
• RNA Metabolism: Role in Human Pathophysiology and Its Potential for Therapeutic Interventions (Deadline: 30 November 2022)
• Advances in Stem Cell Research for Future Therapies and In Vitro Disease Modelling 2.0 (Deadline: 30 November 2022)
• Molecular Mechanisms and Therapeutics of Parkinson's Disease 2022 (Deadline: 30 November 2022)
• The Structural-Functional Rationale for Targeting the Tumor Microenvironment (Deadline: 30 November 2022)
• Understanding Parkinson's Disease (Deadline: 30 November 2022)
• Tissue-Specific Direct and Indirect Effects of Metformin and Its Application 2.0 (Deadline: 30 November 2022)
• TGF-β Signaling in Human Disease (Deadline: 30 November 2022)
• Molecular Mechanisms of Respiratory Diseases (Deadline: 30 November 2022)
• Natural Bioactive Compounds to Promote Cardiovascular Health (Deadline: 30 November 2022)
• Epigenetic Mechanisms and Human Pathology 3.0 (Deadline: 30 November 2022)
• Transcription Factors in Lung Cancer: Mechanisms and Future Perspectives (Deadline: 30 November 2022)
• Cardiovascular Endocrinology Research 2022 (Deadline: 30 November 2022)
• Molecular Sciences in Non-Ischemic Cardiomyopathy (Deadline: 30 November 2022)
• Sympathetic Nerves and Cardiovascular Diseases (Deadline: 30 November 2022)
• Advances in Research on Pulmonary Hypertension 2.0 (Deadline: 30 November 2022)
• Impact of Molecular Biology in the Prevention, Diagnosis and Treatment of Invasive Meningococcal Disease (Deadline: 30 November 2022)
• Transcriptomics in Health and Disease (Deadline: 30 November 2022)
• Advanced Research on Wound Healing (Deadline: 30 November 2022)
• Molecular Research on Platelet Function in Disease 2.0 (Deadline: 30 November 2022)
• Molecular Regulators of Cardiovascular Disease (Deadline: 10 December 2022)
• Rare Diseases—Molecular Mechanisms and Therapeutic Strategies (IV) (Deadline: 30 December 2022)
• Advances in Cardiac Regenerative Medicine (Deadline: 31 December 2022)
• Advances in Antimicrobial Nanoparticles 2022 (Deadline: 31 December 2022)
• Recent Molecular Advances on Diabetic Retinopathy (Deadline: 31 December 2022)
• Molecular Studies in Aging: New Frontiers (Deadline: 31 December 2022)
• MicroRNAs in Periodontal Disease and Systemic Diseases (Deadline: 31 December 2022)
• Soft Tissue Mineralization: Mechanisms, Diseases and Prevention (Deadline: 31 December 2022)
• Connexins Multifaceted Aspects in Homeostasis and Disease (Deadline: 31 December 2022)
• Molecular Advances in Peritoneal Dialysis (Deadline: 31 December 2022)
• Recent Advances of Acute Ischemic Stroke: From the Aspects of Molecular Pathology (Deadline: 31 December 2022)
• Advances in Molecular Science and Genomics: Retinal and Choroidal Diseases (Deadline: 31 December 2022)
• Epigenetic and Transcriptional Control of Skeletal Muscle Homeostasis, Regeneration, and Diseases (Deadline: 31 December 2022)
• Mechanism of Cellular Signaling, Dysfunction and Drug Effects on Liver Diseases (Deadline: 31 December 2022)
• Tetraploid Cells in Health and Disease (Deadline: 31 December 2022)
• Molecular Mechanisms and Treatment of Retinopathy (Deadline: 28 February 2023)
• Lung Diseases: Chronic Respiratory Infections 2.0 (Deadline: 31 March 2023)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Immunopathology and Immunosenescence
• Molecular Aspects of Aging
• Molecular Mechanisms of Human Liver Diseases
• Molecular Understanding of the Exocrine Pancreas and Its Disorders
• Programmed Cell Death and Apoptosis
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Bone and Soft Tissue Diseases in Italy
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in France
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in Italy
• State-of-the-Art Molecular Mechanisms of Hematopathology in France
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in Italy
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in USA